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were expressed at low levels, while Col1a1, VEGF and alpha11
integrin were highly expressed together with TIMP-1, TIMP-2
and MMP-13. Upon osteogenic and chondrogenic differentiation
these genes were differentially regulated. Cytokine and growth
factor profile was assessed at protein level using an antibody ar-
ray. Here, we observed secretion of TIMP-1, MCP-1, VEGFα-165,
while CINC-2 and β-NGF were detected intracellulary. This ex-
pression profile was dependent on differentiation state of MSCs
while other factors embedded into the array could not be detected
irrespective of culture conditions.
Conclusions: Our gene expression results provide a founda-
tion for a more reproducible and reliable quality control of rat
bone marrow derived MSCs used for osteo-chondrogenic dif-
ferentiation studies. Additionally, we demonstrate secretion and
production of cytokines and growth factors from a heteroge-
neous BM cell population which may be crucial for MSCs fate
determination and sustenance.
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Purpose: Chondrocytes are essential to maintain the integrity of
the articular cartilage matrix. Freezing of intact articular cartilage,
even in the presence of cryoprotective agents, like glycerol or
dimethyl sulfoxide, seriously compromises the viability of chon-
drocytes and, thus, the integrity and durability of cryopreserved
osteochondral allografts used to repair several types of cartilage
deffects. This study aims at evaluating the ability of the natural
glycosylated hydroquinone, Arbutin, to protect articular chondro-
cytes from the damaging effects of freeze/thawing, using human
tibial plateaus as a model of osteochondral allografts.
Methods: Tibial plateaus were harvested from cadaver tissue
donors within 24 hours of death, in strictly aseptic conditions
according to the standards of the Tissue and Bone Bank of the
University Hospital of Coimbra, Portugal, and the Portuguese
Transplantation Organization. Donor age ranged from 17 to 53
years old. Articular cartilage from all donors appeared grossly
normal without signs of fibrillation or other lesions. The lateral
and medial tibial plateaus from each cadaver tissue donor were
incubated in Ham F-12 Nutrient Mixture with or without arbutin
(50 or 100 mM) for 30 minutes to 1 hour at 37°C and then
frozen at -20°C/24h. After the initial cooling, the osteochondral
pieces were transferred to a biofreezer at -80°C and kept in those
conditions for a maximum of 2 months. Thawing was achieved
by immersion in Ham F-12 Nutrient Mixture at 37°C for 1h.
Chondrocyte viability was assessed in situ by a modification of
the MTT reduction assay and by staining cryostat sections with
Calcein AM and Propidium Iodide. Where applicable, statistical
analysis was performed using the Student’s t test. Results were
considered significant for p<0.05.
Results: Chondrocyte viability in the osteochondral pieces im-
mediately before freezing, was identical in all the conditions
tested. After freeze/thawing, chondrocyte viability, expressed as
the percent MTT reduction relatively to the viability of chondro-
cytes in fresh cartilage, was significantly higher in tibial plateaus
treated with arbutin than in those treated with the nutrient mix-
ture alone (Control), as shown in table 1. However, fluorescence
microscopy showed that living chondrocytes were restricted to
the superficial cartilage layers.
Results are the mean ± SE of 4 different experiments, each
performed in duplicate.
Table 1. Chondrocyte viability in freeze/thawed cartilage relatively to the fresh
tissue
Control Arbutin, Arbutin, Arbutin,
50mM, 30 min 50mM, 1h 100mM, 30 min
11.1 ± 9.4 32.0 ± 10.8 34,2 ± 2.9 28,5 ± 6.2
Conclusions: The results presented indicate that Arbutin is a low
toxicity cryoprotective agent that effectively preserves chondro-
cyte viability, at least, in the superficial cartilage layers. Neverthe-
less, further studies are required to identify conditions of cryop-
reservation with this natural compound that allow the protection
of chondrocytes in the entire depth of the articular cartilage,
which is essential to maintain cartilage integrity in cryopreserved
osteochondral allografts.
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Purpose: Osteoarthritis (OA) as the most prevalent disorder of
the musculoskeletal system is a consequence of mechanical
and biological events destabilizing tissue homeostasis in articu-
lar joint tissues. Thus, it involves the disturbance in the normal
balance of degradation and repair in articular cartilage, synovial
membrane and subchondral bone. Current means and surgical
procedures for an efficient treatment are restricted to symp-
tomatic measures or are quite unsatisfactory in the long-term
evaluation. Tissue Engineering (TE) provides new sustainable
therapy strategies based on the transplantation of cells as sus-
pensions or in combination with scaffolds to the defect side.
Mesenchymal progenitor cells like mesenchymal stem cells and
periosteal progenitor cells meet the demands of regenerating
complex defects like articular knee cartilage and the underlying
bone occurring due OA progression.
Since several years we investigate the regenerative properties
of periosteal progenitor cells. In a new approach we developed
three-dimensional (3D) cell culture techniques comprising the
use of periosteal progenitor cells mixed with fibrinogen and em-
bedded in PGLA biomaterials to allow the formation of osseous
and cartilaginous tissue in vitro and in animal models. The aim of
this study was to characterize human cartilage and bone tissue
engineering on the molecular level.
Methods: With regard to a possible translation into the clinic,
we performed the experiments in a clinically applicable setting:
Human periosteal cells from mastoid (n=3) were isolated and
cultured in complete DME-medium containing human serum.
Passage 3 cells were mixed with human fibrinogen, embed-
ded in PGLA fleeces and induced according to osteogenic or
chondrogenic standard protocols.
Results: After one, two and four weeks of osteogenic induction
the formation of mineralized bone matrix was shown by von
Kossa staining. Chondrogenic differentiation was demonstrated
by collagen type II immunohistochemistry and by alcian blue
staining after two, four and six weeks of induction. Cell viability
was investigated by using PI/FDA staining. RNA from culture
expanded periosteal progenitor cells, 3D bone grafts (timepoint:
7, 14 and 28 days), native bone, 3D cartilage graft (timepoint:
14, 28 and 42 days) and native cartilage were used for genom-
wide gene expression profiling analysis using the Affymetrix HG
U133 plus 2.0 oligonucleotid microarray. The analysis by pat-
tern discovery displayed the regulation of distinct genes already
described as relevant in osteogenesis and chondrogenesis, like
genes involved in matrix formation, and also of possible new
marker genes.
